Denise Myshko

Pharmacy benefit managers are moving beyond formulary access to provide support programs for women's health. Here's how three PBMs — Judi Health, LucyRx and RxPreferred — are putting that strategy into practice.

Women face more gaps in healthcare than men, from missed screenings, undertreatment and biased coverage. PBMs are launching programs to address some of the gaps.

UC San Diego researchers found that early-onset metabolic dysfunction-associated steatotic liver disease cirrhosis was linked to higher genetic risk and Type 2 diabetes prevalence.

UCLA research suggests that GLP-1 therapies may protect bone health in Type 2 diabetes patients.

A new Spherix Global Insights survey shows providers want administrative support for prior authorization while patients prioritize access and affordability

Onswik is approved to improve glycemic control in adults with Type 2 diabetes and will be available in the United States in the coming months in two concentrations. No information is available on the list price.

In both mice and human cells, a small molecule selectively blocked the activity of MAP4K4, a protein involved in several major biological pathways.

CMS transparency rules and AI could bring “Expedia-like” drug price comparisons for consumers, but payer compliance to transparency rules remains low.

A number of pharmacy benefit managers are creating programs geared to the healthcare needs of women.

GLP-1 drug spending surges and rewires diabetes care as session at teh 2026 PBMI Annual National Conference spotlight PBM disruption, AI-driven actionable data, and new state reporting rules.